| Jennifer R Seifert, DPM | |
|
4051 Ogletown Rd Ste 102, Newark, DE 19713-3101 | |
| (302) 731-2888 | |
| (302) 731-7049 |
| Full Name | Jennifer R Seifert |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 12 Years |
| Location | 4051 Ogletown Rd Ste 102, Newark, Delaware |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114284106 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | E1-0000234 (Delaware) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Christiana Hospital | Newark, DE | Hospital |
| Bayhealth Hospital, Kent Campus | Dover, DE | Hospital |
| Union Hospital Of Cecil County | Elkton, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| First State Orthopaedics Pa | 6103800057 | 69 |
| First State Orthopaedics Pa | 6103800057 | 69 |
| Rehabclinics Spt Inc | 7113834102 | 298 |
News Archive
For reasons that remain unclear at least in the smaller babies, both birthweight extremes appear to increase the likelihood of early development of dangerous fat around major organs in the abdomen that significantly increases these risks, said Dr. Brian Stansfield, neonatologist at the Children's Hospital of Georgia and the Medical College of Georgia at Augusta University.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
The inert gas has been used for the first time to try and reduce the impact of traumatic brain injuries (TBI) caused by blasts such as those in conflict zones and terror attacks.
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
› Verified 3 days ago
| Provider Name | First State Orthopaedics Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1346220266 PECOS PAC ID: 6103800057 Enrollment ID: O20040617000139 |
News Archive
For reasons that remain unclear at least in the smaller babies, both birthweight extremes appear to increase the likelihood of early development of dangerous fat around major organs in the abdomen that significantly increases these risks, said Dr. Brian Stansfield, neonatologist at the Children's Hospital of Georgia and the Medical College of Georgia at Augusta University.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
The inert gas has been used for the first time to try and reduce the impact of traumatic brain injuries (TBI) caused by blasts such as those in conflict zones and terror attacks.
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
› Verified 3 days ago
| Provider Name | Christiana Care Health Services Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821302472 PECOS PAC ID: 9739097569 Enrollment ID: O20110610000296 |
News Archive
For reasons that remain unclear at least in the smaller babies, both birthweight extremes appear to increase the likelihood of early development of dangerous fat around major organs in the abdomen that significantly increases these risks, said Dr. Brian Stansfield, neonatologist at the Children's Hospital of Georgia and the Medical College of Georgia at Augusta University.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
The inert gas has been used for the first time to try and reduce the impact of traumatic brain injuries (TBI) caused by blasts such as those in conflict zones and terror attacks.
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer R Seifert, DPM 211 Executive Dr Ste 11, Newark, DE 19702-3358 Ph: (302) 731-2888 | Jennifer R Seifert, DPM 4051 Ogletown Rd Ste 102, Newark, DE 19713-3101 Ph: (302) 731-2888 |
News Archive
For reasons that remain unclear at least in the smaller babies, both birthweight extremes appear to increase the likelihood of early development of dangerous fat around major organs in the abdomen that significantly increases these risks, said Dr. Brian Stansfield, neonatologist at the Children's Hospital of Georgia and the Medical College of Georgia at Augusta University.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
The inert gas has been used for the first time to try and reduce the impact of traumatic brain injuries (TBI) caused by blasts such as those in conflict zones and terror attacks.
BioTime, Inc. today reported recently-released results from an independent study evaluating the use of Hextend® in hemodynamically unstable trauma patients. Hextend (6% Hetastarch in Lactated Electrolyte Injection) is BioTime's commercially-available blood plasma volume expander used to treat hypovolemia (low blood volume). The study, conducted at the University of Miami Ryder Trauma Center, reported that initial resuscitation with Hextend was associated with no obvious coagulopathy and reduced mortality compared to fluid resuscitation without Hextend.
› Verified 3 days ago
New Castle Associates In Podiatry Podiatrist Medicare: Medicare Enrolled Practice Location: 620 Stanton Christiana Rd, Suite 303 Metroform Medical Complex, Newark, DE 19713 Phone: 302-999-8511 Fax: 302-999-8645 | |
Foot And Ankle Associates Llp Podiatrist Medicare: Medicare Enrolled Practice Location: 2600 Glasgow Ave, Suite 107, Newark, DE 19702 Phone: 302-834-3575 Fax: 302-834-4066 | |
Foot And Ankle Associates Llp Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 15 Omega Dr Bldg K, Newark, DE 19713 Phone: 302-834-3575 | |
Peter E Larned, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4051 Ogletown Rd Ste 102, Newark, DE 19713 Phone: 302-731-2888 Fax: 302-731-7049 | |
Benjamin Russell Denenberg, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4051 Ogletown Rd Ste 102, Newark, DE 19713 Phone: 302-731-2888 Fax: 302-731-7049 | |
Advantage Foot And Ankle Center Pa Podiatrist Medicare: Medicare Enrolled Practice Location: 1 Centurian Dr, Suite 101, Newark, DE 19713 Phone: 302-994-5275 Fax: 302-994-1794 |